Genetic Variation in Metabolizing Enzyme and Transporter Genes: Comprehensive Assessment in 3 Major East Asian Subpopulations With Comparison to Caucasians and Africans
Authors:
- 1 August 2010
- journal article
- research article
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 50 (8) , 929-940
Abstract
The advent of high‐throughput technologies has proven valuable in the assessment of genetic differences and their effects on drug activation, metabolism, disposition, and transport. However, most studies to date have focused on a small number of genes or few alleles, some of which are rare and therefore observed infrequently or lacked rigorous ethnic characterization, thus reducing the ability to extrapolate within and among populations. In this study, the authors comprehensively assessed the allele frequencies of 165 variants comprising 27 drug‐metabolizing enzyme and transporter (DMET) genes from 2188 participants across 3 major ethnic populations: Caucasians, Africans, and East Asians. This sample size was sufficiently large to demonstrate genetic differences among these major ethnic groups while concomitantly confirming similarities among East Asian subpopulations (Korean, Han Chinese, and Japanese). A comprehensive presentation of allele and genotype frequencies is included in the online supplement, and 3 of the most widely studied cytochrome P450 (CYP) genes, CYP2D6, CYP2C19, and CYP2C9; 2 non‐CYP enzymes, NAT1 and TMPT; and 2 transporter genes, SLCO1B1 and SLCO2B1, are presented herein according to ethnic classification.Keywords
This publication has 77 references indexed in Scilit:
- Cytochrome P-450 Polymorphisms and Response to ClopidogrelNew England Journal of Medicine, 2009
- Genetic Determinants of Response to Clopidogrel and Cardiovascular EventsNew England Journal of Medicine, 2009
- Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort studyThe Lancet, 2009
- Genetic Variation in Drug Transporters in Ethnic PopulationsClinical Pharmacology & Therapeutics, 2008
- Worldwide distribution of NAT2 diversity: Implications for NAT2 evolutionary historyBMC Genomic Data, 2008
- Genetics of P450 oxidoreductase: Sequence variation in 842 individuals of four ethnicities and activities of 15 missense mutationsProceedings of the National Academy of Sciences, 2008
- Atomoxetine pharmacokinetics in healthy Chinese subjects and effect of the CYP2D6*10 alleleBritish Journal of Clinical Pharmacology, 2007
- Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin actionJournal of Clinical Investigation, 2007
- Genetic affinities between endogamous and inbreeding populations of Uttar PradeshBMC Genomic Data, 2007
- The influence of CYP2D6 phenotype on the clinical response of nebivolol in patients with essential hypertensionBritish Journal of Clinical Pharmacology, 2007